al-Habet SM[au] - Search Results

Year	Number of Results
1981	1
1983	1
1985	1
1986	1
1989	5
1990	2
1993	2
1994	1
2024	0

1

Methylprednisolone pharmacokinetics after intravenous and oral administration.

Al-Habet SM, Rogers HJ. Al-Habet SM, et al. Br J Clin Pharmacol. 1989 Mar;27(3):285-90. doi: 10.1111/j.1365-2125.1989.tb05366.x. Br J Clin Pharmacol. 1989. PMID: 2655680 Free PMC article. Clinical Trial.

2

Prednisolone elimination in human saliva.

Al-Habet SM, Rogers HJ. Al-Habet SM, et al. Int J Clin Pharmacol Ther Toxicol. 1985 Sep;23(9):485-7. Int J Clin Pharmacol Ther Toxicol. 1985. PMID: 4055160

3

Rifampicin reduces effectiveness and bioavailability of prednisolone.

McAllister WA, Thompson PJ, Al-Habet SM, Rogers HJ. McAllister WA, et al. Among authors: al habet sm. Br Med J (Clin Res Ed). 1983 Mar 19;286(6369):923-5. doi: 10.1136/bmj.286.6369.923. Br Med J (Clin Res Ed). 1983. PMID: 6403136 Free PMC article.

4

Interaction of zidovudine (azidothymidine) with isoprinosine and probenecid in Macaca fascicularis.

al-Habet SM, Nosbisch C, Williamson T, Tsai CC, Unadkat JD. al-Habet SM, et al. Pharm Res. 1994 Jan;11(1):181-3. doi: 10.1023/a:1018982703049. Pharm Res. 1994. PMID: 7511239 No abstract available.

5

Disposition of drugs in cystic fibrosis. V. In vivo CYP2C9 activity as probed by (S)-warfarin is not enhanced in cystic fibrosis.

O'Sullivan TA, Wang JP, Unadkat JD, al-Habet SM, Trager WF, Smith AL, McNamara S, Aitken ML. O'Sullivan TA, et al. Among authors: al habet sm. Clin Pharmacol Ther. 1993 Sep;54(3):323-8. doi: 10.1038/clpt.1993.154. Clin Pharmacol Ther. 1993. PMID: 8375128

6

Disposition of drugs in cystic fibrosis. IV. Mechanisms for enhanced renal clearance of ticarcillin.

Wang JP, Unadkat JD, al-Habet SM, O'Sullivan TA, Williams-Warren J, Smith AL, Ramsey B. Wang JP, et al. Among authors: al habet sm. Clin Pharmacol Ther. 1993 Sep;54(3):293-302. doi: 10.1038/clpt.1993.150. Clin Pharmacol Ther. 1993. PMID: 8375124

7

In vitro hydrolysis of steroid acid ester derivatives of prednisolone in plasma of different species.

al-Habet SM, Lee HJ. al-Habet SM, et al. J Pharm Sci. 1990 Oct;79(10):916-8. doi: 10.1002/jps.2600791015. J Pharm Sci. 1990. PMID: 2280362

8

Effect of food on the absorption and pharmacokinetics of prednisolone from enteric-coated tablets.

Al-Habet SM, Rogers HJ. Al-Habet SM, et al. Eur J Clin Pharmacol. 1989;37(4):423-6. doi: 10.1007/BF00558515. Eur J Clin Pharmacol. 1989. PMID: 2598978

9

Urinary excretion of prednisolone following intravenous administration in humans.

al-Habet SM, Rogers HJ. al-Habet SM, et al. J Clin Pharmacol. 1989 Oct;29(10):922-7. doi: 10.1002/j.1552-4604.1989.tb03256.x. J Clin Pharmacol. 1989. PMID: 2592584

10

Pharmacokinetics of prednisolone and its local anti-inflammatory steroid-21-oate ester derivatives. In vitro and in vivo comparative study.

al-Habet SM, Taraporewala IB, Lee HJ. al-Habet SM, et al. Drug Metab Dispos. 1990 Jan-Feb;18(1):55-60. Drug Metab Dispos. 1990. PMID: 1970778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

14 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year